AMYPAD study cases presented at SNMMI 2021

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting is recognised as the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging.

This year, the event took place online from 11-15 June. The four-day event provided physicians, technologists, pharmacists, laboratory professionals, and scientists with an in-depth view of the latest research and development in the field as well as provided insights into practical applications for the clinic.

Our Project Co-Lead Gill Farrar moderated a satellite symposium entitled “Neurology and Nuclear Medicine: Working Together for an Optimal Dementia Diagnosis” sponsored by GE Healthcare. During this symposium, Valentina Garibotto and Giovanni Frisoni, from the Geneva University and Geneva University Hospital, explored interesting cases taken from the AMYPAD Diagnostic and Patient Management Study and highlighted the value of the close working relationship between their respective Neurology and Nuclear Medicine Departments.

The recording will be available soon.

Further information on the conference can be found here.

 

Follow us on Twitter: @IMI_AMYPAD

Receive the latest news. Click here to subscribe!

AMYPAD study cases presented at SNMMI 2021
More News